Big news today from Venus Remedies, as the company confirmed receiving the final Rs 11 crore milestone from Cipla for its novel AMR-focused anti-infective. This marks the completion of all commercial milestones agreed under their 2019 deal...
Novo Nordisk has officially closed its acquisition of Akero Therapeutics, marking a major move in the race to develop next-generation treatments for metabolic liver diseases. The deal, first announced on October 9, 2025, is now fully completed...
Pfizer is drawing global attention today with new Phase 3 data showing its investigational therapy HYMPAVZI could shift treatment for people with hemophilia A or B who develop inhibitors. These patients often face some of the toughest treatment...
India’s rising weight burden is pushing healthcare forward, and Agilus Diagnostics is stepping in with a bold move. The company has rolled out its new obesity test suite, built to give clinicians deeper insight into insulin resistance, metabolic...
Immutep has sealed a wide-reaching licensing pact with Dr Reddy’s Laboratories, giving the Indian drugmaker exclusive rights to develop and commercialize Eftilagimod Alfa (efti) across most global markets, except North America, Europe, Japan, and...
Trivitron Healthcare and ResoHealth have established a joint venture called Trivitron Digital.AI (TDAI), which is a cutting-edge digital health initiative designed to address the existing adoption gaps on a large scale
Viatris is set to sell its stake in Biocon Biologics, a move that could reshape its position in the global pharmaceutical market. Under the definitive agreement, Viatris will transfer its entire convertible preferred equity in Biocon Biologics...
.png "Takeda Strengthens Cancer Portfolio Through Innovent Partnership")
Takeda has signed a license and collaboration agreement with Innovent Biologics and satisfied all the terms and transitioned the collaboration to the implementation phase. The deal that was initially unveiled in October of 2025 enhances the...
India is exploring options to enhance the World Health Organisation (WHO) global benchmarking standards for medicines, aimed at standardizing and reinforcing the drug regulatory system for the safety, quality, and effectiveness of medications
Bayer’s investigational MRI contrast agent gadoquatrane is drawing industry attention today after new pediatric data strengthened its safety and performance profile. The company revealed fresh results from its QUANTI Pediatric study at the RSNA...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")